Evidence for a Difference in Nitric Oxide Biosynthesis Between Healthy Women and Men
There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 32; no. 4; pp. 730 - 734 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.10.1998
Hagerstown, MD Lippincott |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-[() N] (2-guanidino) arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 [micro sign]mol L-[() N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary N/() N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary N nitrate excretion was greater in women than in men (2111 +/- 139 versus 1682 +/- 87 eta mol; P<0.05). Furthermore, total urinary N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.) |
---|---|
AbstractList | Abstract
—There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of
15
N nitrate excreted in urine after the intravenous administration of
l
-[
15
N]
2
-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 μmol
l
-[
15
N]
2
arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary
15
N/
14
N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary
15
N nitrate excretion was greater in women than in men (2111±139 versus 1682±87 ηmol;
P
<0.05). Furthermore, total urinary
15
N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47;
P
=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women.There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15N nitrate excreted in urine after the intravenous administration of L-[15N]2-guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 micromol L-[15N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15N/14N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15N nitrate excretion was greater in women than in men (2111+/-139 versus 1682+/-87 etamol; P<0.05). Furthermore, total urinary 15N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of N nitrate excreted in urine after the intravenous administration of L-[() N] (2-guanidino) arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 [micro sign]mol L-[() N]2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary N/() N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary N nitrate excretion was greater in women than in men (2111 +/- 139 versus 1682 +/- 87 eta mol; P<0.05). Furthermore, total urinary N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; P=0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.) |
Author | Chowienczyk, Phil J. Johnston, Atholl Kneale, Barry J. Milne, Eric Benjamin, Nigel Forte, Pablo Ritter, James M. |
AuthorAffiliation | Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk |
AuthorAffiliation_xml | – name: Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk |
Author_xml | – sequence: 1 givenname: Pablo surname: Forte fullname: Forte, Pablo organization: Received April 27, 1998; first decision May 12, 1998; revision accepted June 18, 1998. From the Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, London (P.F., A.J., N.B.); the Department of Clinical Pharmacology, UMDS, St Thomas' Hospital, London (B.J.K., P.J.C., J.M.R.); and the Rowett Research Institute, Aberdeen (E.M.), UK. Presented as an oral presentation at the 5th International Meeting on Biology of Nitric Oxide, Kyoto, Japan, September 15-19, 1997; published in abstract form (Jpn J Pharmacol. 1997;75:16P). Correspondence to Professor Nigel Benjamin, Department of Clinical Pharmacology, St Bartholomew's and The Royal School of Medicine and Dentistry, Charterhouse Square, London, EC1 M 6BQ, UK. E-mail n.benjamin@mds.qmw.ac.uk – sequence: 2 givenname: Barry J. surname: Kneale fullname: Kneale, Barry J. – sequence: 3 givenname: Eric surname: Milne fullname: Milne, Eric – sequence: 4 givenname: Phil J. surname: Chowienczyk fullname: Chowienczyk, Phil J. – sequence: 5 givenname: Atholl surname: Johnston fullname: Johnston, Atholl – sequence: 6 givenname: Nigel surname: Benjamin fullname: Benjamin, Nigel – sequence: 7 givenname: James M. surname: Ritter fullname: Ritter, James M. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2421241$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9774371$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1vEzEQxS1UVNLCmRPSCqHeduvxx-76SEshSIVyKAJOluOMFZeNHewNaf57nCbqoQcsWdbz_N5oNO-EHIUYkJDXQBuAFs4pNIvtquGsEU3H6TMyAclELWTLj8iEghK1Avj5gpzkfEcpCCG6Y3Ksuk7wDibk9uqvn2OwWLmYKlN98M5hevjwofrqx-RtdXNfmOrCx7wN4wKzz9UFjhvEUE3RDONiW_2Iy6JMmFdfMLwkz50ZMr46vKfk-8er28tpfX3z6fPl--vaSkr7GqHnzPVKurazvXBCSGe5kaikoM7M0PRmJgCt4xS4tL2bsdZSMIqhEYbxU3K277tK8c8a86iXPlscBhMwrrNuleoolaqAb5-Ad3GdQplNMypZLyjjBXpzgNazJc71KvmlSVt92FWpvzvUTbZmcMkE6_MjxgQDJnbY-R6zKeac0D0SQPUuM01BT39905xpoUtmxSGfOKwfzehjGJPxw398Yu_bxGHElH8P6w0mvXiIRNNyBGv7GpTqYafqcsvK_wFP8qj1 |
CODEN | HPRTDN |
CitedBy_id | crossref_primary_10_1152_ajpregu_00338_2003 crossref_primary_10_3390_jcm9123815 crossref_primary_10_1139_cjpp_2015_0272 crossref_primary_10_1002_cbdv_202400175 crossref_primary_10_1016_j_niox_2004_07_008 crossref_primary_10_1016_j_ijcard_2016_11_118 crossref_primary_10_1113_EP085148 crossref_primary_10_1016_j_schres_2018_12_015 crossref_primary_10_14814_phy2_13200 crossref_primary_10_1378_chest_14_0263 crossref_primary_10_1080_07420520600827129 crossref_primary_10_1371_journal_pone_0219481 crossref_primary_10_3109_00365513_2012_701322 crossref_primary_10_1152_ajpregu_00226_2013 crossref_primary_10_1016_j_bcp_2023_115737 crossref_primary_10_1183_16000617_0330_2020 crossref_primary_10_1590_S1517_86922006000400001 crossref_primary_10_1093_gerona_gls171 crossref_primary_10_1042_CS20040078 crossref_primary_10_1002_dmrr_3059 crossref_primary_10_1016_S0891_5849_03_00104_7 crossref_primary_10_1586_14779072_5_4_777 crossref_primary_10_1016_j_jpet_2025_103526 crossref_primary_10_1152_ajprenal_00228_2020 crossref_primary_10_1152_physiol_00001_2008 crossref_primary_10_1080_10408398_2011_651177 crossref_primary_10_1177_1091581809345924 crossref_primary_10_1152_ajpheart_00194_2018 crossref_primary_10_1152_ajpregu_00526_2009 crossref_primary_10_3390_nu11050954 crossref_primary_10_1111_apha_13637 crossref_primary_10_1086_683829 crossref_primary_10_1016_S1089_8603_02_00105_2 crossref_primary_10_2217_14796678_3_3_283 crossref_primary_10_1089_jwh_2010_2115 crossref_primary_10_1007_s11033_012_1492_4 crossref_primary_10_1152_ajpheart_00519_2017 crossref_primary_10_1016_j_niox_2021_11_001 crossref_primary_10_1002_nau_1006 crossref_primary_10_1016_j_atherosclerosis_2007_06_008 crossref_primary_10_1186_s12902_021_00817_3 crossref_primary_10_1371_journal_pone_0080101 crossref_primary_10_1016_j_semnephrol_2022_04_006 crossref_primary_10_1042_BSR20180111 crossref_primary_10_14814_phy2_15644 crossref_primary_10_1089_ars_2021_0212 crossref_primary_10_1016_j_cbpb_2004_02_022 crossref_primary_10_1172_JCI31093 crossref_primary_10_1371_journal_pone_0300844 crossref_primary_10_1186_s12931_023_02531_1 crossref_primary_10_1046_j_1444_2892_2000_009003113_x crossref_primary_10_3109_00365521_2013_773459 crossref_primary_10_1152_japplphysiol_00099_2003 crossref_primary_10_1093_jn_134_10_2768S crossref_primary_10_1038_sj_bjp_0706422 crossref_primary_10_1042_CS20240625 crossref_primary_10_1152_ajprenal_00009_2002 crossref_primary_10_1371_journal_pone_0009257 crossref_primary_10_1097_00075197_200301000_00015 crossref_primary_10_3945_jn_116_231910 crossref_primary_10_1007_s00431_013_1988_5 crossref_primary_10_14814_phy2_12125 crossref_primary_10_1016_j_lpm_2016_10_005 crossref_primary_10_1111_jch_12493 crossref_primary_10_1152_japplphysiol_00452_2007 crossref_primary_10_3390_ijerph10072813 crossref_primary_10_1111_apha_13937 crossref_primary_10_1093_gerona_gly087 crossref_primary_10_1016_j_jash_2007_02_002 crossref_primary_10_1269_jrr_07070 crossref_primary_10_1111_j_1475_097X_2009_00884_x crossref_primary_10_1007_s11906_016_0689_7 crossref_primary_10_1021_jasms_1c00055 crossref_primary_10_1002_cbf_3741 crossref_primary_10_1590_S0102_86502002000600011 crossref_primary_10_1159_000355741 crossref_primary_10_3109_10739680903199186 crossref_primary_10_1016_j_niox_2014_03_162 crossref_primary_10_1111_j_1365_2362_2004_01339_x crossref_primary_10_1002_ajh_23613 crossref_primary_10_1016_S0168_8227_02_00180_8 crossref_primary_10_1161_JAHA_114_001738 crossref_primary_10_1152_ajpheart_00142_2018 crossref_primary_10_3389_fphys_2019_00749 crossref_primary_10_1152_ajpheart_00823_2016 crossref_primary_10_1080_09537100701525843 crossref_primary_10_1097_HJH_0b013e32835731dd crossref_primary_10_1016_j_semnephrol_2009_07_003 crossref_primary_10_1016_j_cjca_2014_03_020 crossref_primary_10_1016_j_lfs_2024_122432 crossref_primary_10_1016_j_mam_2011_02_001 crossref_primary_10_1038_sj_ki_5001680 crossref_primary_10_1016_j_atherosclerosis_2011_04_007 crossref_primary_10_1152_ajprenal_00482_2016 crossref_primary_10_1016_j_chest_2024_01_014 crossref_primary_10_1097_00004872_199917080_00001 crossref_primary_10_1002_jnr_23855 crossref_primary_10_1038_hr_2014_140 crossref_primary_10_1152_ajpendo_00527_2014 crossref_primary_10_6118_jmm_2018_24_2_75 crossref_primary_10_1097_00004872_200205000_00021 crossref_primary_10_1016_j_steroids_2013_01_003 crossref_primary_10_1152_ajpregu_00214_2007 crossref_primary_10_3389_fcvm_2023_1198090 crossref_primary_10_5402_2012_901801 crossref_primary_10_1007_s00380_018_1140_6 crossref_primary_10_1038_ajh_2009_155 crossref_primary_10_1186_s40168_020_00913_x crossref_primary_10_1007_BF03345214 crossref_primary_10_1038_nrneph_2009_90 crossref_primary_10_1111_j_1440_1681_2007_04732_x crossref_primary_10_4244_EIJ_D_19_00774 crossref_primary_10_1093_jn_nxaa318 crossref_primary_10_1007_s11906_002_0039_9 crossref_primary_10_1016_j_phrs_2011_08_009 crossref_primary_10_1038_jcbfm_2012_141 crossref_primary_10_1210_jcem_85_4_6530 crossref_primary_10_1007_s10545_008_0920_z crossref_primary_10_17116_profmed201821248_54 crossref_primary_10_1093_ajcn_nqac277 crossref_primary_10_1016_j_freeradbiomed_2011_05_032 crossref_primary_10_1097_MD_0000000000034182 crossref_primary_10_1016_j_humimm_2008_03_003 crossref_primary_10_1152_ajprenal_00666_2013 crossref_primary_10_1203_01_pdr_0000214880_15623_84 crossref_primary_10_1186_s13102_021_00292_2 crossref_primary_10_1016_j_phrs_2016_10_018 crossref_primary_10_1093_ndt_gfl227 crossref_primary_10_1007_s43440_023_00499_9 crossref_primary_10_5812_scimetr_20987 crossref_primary_10_1093_nutrit_nuy005 crossref_primary_10_1016_j_vph_2009_05_002 crossref_primary_10_1042_CS20160047 crossref_primary_10_1186_1471_2369_11_20 crossref_primary_10_1016_j_hfc_2022_09_002 crossref_primary_10_1177_1753944707088904 crossref_primary_10_1067_mhl_2001_118764 crossref_primary_10_1016_j_vph_2017_09_003 crossref_primary_10_1177_2045894021989554 crossref_primary_10_1111_bph_14783 crossref_primary_10_23736_S0393_3660_19_04247_5 crossref_primary_10_1164_ajrccm_162_2_9909124 crossref_primary_10_1093_cvr_cvq309 crossref_primary_10_6118_jmm_2014_20_1_1 crossref_primary_10_1016_j_phrs_2017_01_023 crossref_primary_10_1366_000370206776023241 crossref_primary_10_1371_journal_pone_0090232 crossref_primary_10_1007_s40200_021_00799_y crossref_primary_10_1139_apnm_2017_0696 crossref_primary_10_1146_annurev_pharmtox_010919_023229 crossref_primary_10_1016_j_genm_2008_03_006 |
Cites_doi | 10.1021/bi00424a003 10.1161/res.73.6.8222083 10.1126/science.181.4105.1125 10.1006/bbrc.1994.2107 10.1016/0006-291X(85)90080-4 10.1136/hrt.72.3.243 10.1097/00004872-199209000-00017 10.1161/circ.81.6.2344673 10.1093/oso/9780192623683.003.0002 10.1111/j.1475-097X.1996.tb00726.x 10.1056/NEJM199312303292706 10.1016/0024-3205(95)02311-9 10.1016/S0140-6736(96)07631-3 10.1093/clinchem/35.6.1024 10.1152/ajpcell.1995.269.4.C884 10.2136/sssaj1989.03615995005300060016x 10.1177/000456329703400212 10.1016/S0140-6736(94)91285-8 10.1201/b14095 10.1016/S0140-6736(94)91342-0 10.1097/00005344-199204002-00061 10.1097/00010694-195811000-00011 |
ContentType | Journal Article |
Copyright | 1998 American Heart Association, Inc. 1998 INIST-CNRS Copyright American Heart Association, Inc. Oct 1998 |
Copyright_xml | – notice: 1998 American Heart Association, Inc. – notice: 1998 INIST-CNRS – notice: Copyright American Heart Association, Inc. Oct 1998 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1161/01.hyp.32.4.730 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 734 |
ExternalDocumentID | 35166915 9774371 2421241 10_1161_01_HYP_32_4_730 00004268-199810000-00018 |
Genre | Comparative Study Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP CITATION IQODW OZ- ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW RHF K9. 7X8 |
ID | FETCH-LOGICAL-c5008-e1832f895f67c84f445fc3a5e9540fabea8ab41ecf30135c8fb26c01a92ea4a23 |
ISSN | 0194-911X |
IngestDate | Tue Aug 05 10:50:06 EDT 2025 Fri Jul 25 07:10:02 EDT 2025 Wed Feb 19 02:36:13 EST 2025 Mon Jul 21 09:15:55 EDT 2025 Thu Apr 24 23:08:15 EDT 2025 Tue Jul 01 01:44:28 EDT 2025 Fri May 16 03:51:27 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Nitric oxide Blood vessel Sex Female Male Biosynthesis Circulatory system Comparative study Endothelium |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5008-e1832f895f67c84f445fc3a5e9540fabea8ab41ecf30135c8fb26c01a92ea4a23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 |
PMID | 9774371 |
PQID | 205284023 |
PQPubID | 47910 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_69970059 proquest_journals_205284023 pubmed_primary_9774371 pascalfrancis_primary_2421241 crossref_primary_10_1161_01_HYP_32_4_730 crossref_citationtrail_10_1161_01_HYP_32_4_730 wolterskluwer_health_00004268-199810000-00018 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1998-October |
PublicationDateYYYYMMDD | 1998-10-01 |
PublicationDate_xml | – month: 10 year: 1998 text: 1998-October |
PublicationDecade | 1990 |
PublicationPlace | Philadelphia, PA Hagerstown, MD |
PublicationPlace_xml | – name: Philadelphia, PA – name: Hagerstown, MD – name: United States – name: Baltimore |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 1998 |
Publisher | American Heart Association, Inc Lippincott |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott |
References | e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 (e_1_3_2_10_2) 1982; 126 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 (e_1_3_2_20_2) 1995; 26 |
References_xml | – ident: e_1_3_2_16_2 doi: 10.1021/bi00424a003 – ident: e_1_3_2_15_2 doi: 10.1161/res.73.6.8222083 – ident: e_1_3_2_18_2 doi: 10.1126/science.181.4105.1125 – ident: e_1_3_2_24_2 doi: 10.1006/bbrc.1994.2107 – volume: 26 start-page: E360 year: 1995 ident: e_1_3_2_20_2 publication-title: Am J Physiol – ident: e_1_3_2_8_2 doi: 10.1016/0006-291X(85)90080-4 – ident: e_1_3_2_4_2 doi: 10.1136/hrt.72.3.243 – ident: e_1_3_2_22_2 doi: 10.1097/00004872-199209000-00017 – ident: e_1_3_2_23_2 doi: 10.1161/circ.81.6.2344673 – ident: e_1_3_2_14_2 doi: 10.1093/oso/9780192623683.003.0002 – ident: e_1_3_2_7_2 – ident: e_1_3_2_17_2 doi: 10.1111/j.1475-097X.1996.tb00726.x – ident: e_1_3_2_2_2 doi: 10.1056/NEJM199312303292706 – ident: e_1_3_2_5_2 doi: 10.1016/0024-3205(95)02311-9 – ident: e_1_3_2_9_2 doi: 10.1016/S0140-6736(96)07631-3 – ident: e_1_3_2_21_2 doi: 10.1093/clinchem/35.6.1024 – ident: e_1_3_2_19_2 doi: 10.1152/ajpcell.1995.269.4.C884 – ident: e_1_3_2_11_2 doi: 10.2136/sssaj1989.03615995005300060016x – ident: e_1_3_2_25_2 doi: 10.1177/000456329703400212 – ident: e_1_3_2_1_2 doi: 10.1016/S0140-6736(94)91285-8 – ident: e_1_3_2_13_2 doi: 10.1201/b14095 – ident: e_1_3_2_3_2 doi: 10.1016/S0140-6736(94)91342-0 – ident: e_1_3_2_6_2 doi: 10.1097/00005344-199204002-00061 – ident: e_1_3_2_12_2 doi: 10.1097/00010694-195811000-00011 – volume: 126 start-page: 131 year: 1982 ident: e_1_3_2_10_2 publication-title: Anal Chem |
SSID | ssj0014447 |
Score | 2.031583 |
Snippet | There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO... Abstract —There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 730 |
SubjectTerms | Adult Arginine - administration & dosage Arginine - metabolism Biological and medical sciences Blood Pressure Blood vessels and receptors Body Mass Index Female Fundamental and applied biological sciences. Psychology Humans Injections, Intravenous Male Muscle, Smooth, Vascular - metabolism Nitrates - urine Nitric Oxide - biosynthesis Sex Characteristics Vertebrates: cardiovascular system |
Title | Evidence for a Difference in Nitric Oxide Biosynthesis Between Healthy Women and Men |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-199810000-00018 https://www.ncbi.nlm.nih.gov/pubmed/9774371 https://www.proquest.com/docview/205284023 https://www.proquest.com/docview/69970059 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqISEkhLhNhDHwAw9IU0KcOLfHAUWFrgWkTnS8WI5raxOQVmsrVn49x5dcOhVxeUlb13ainM_H526EnpeJkoCdyI_KPPEpKBh-EYUzn8BmkHGSl5kxuI3G6eCUvp8m015v3c0uWZWB-Lkzr-R_qAptQFedJfsPlG0mhQb4DvSFK1AYrn9F4_pIUBsK2Rx2IkwhEFirOkp-fgV9jsqL-XJTgbCn64_UsVk2B3JjqzAYL8J3lxjmpNUBKKmXJsTdYCR_o63uNq5IXgVHpMiKjiUB9MlJfytlbDjuH5-YpldB638avTsZ97eTIAYfPmtb15ezoRlfd5416Xl1XJuzRjRVJbo2y4JqnjrtMt3WqNlaFAwHzZybRrpfdDefT4nJXQjON4sgjgIaNOO6FbWv7XRN_KHxg-tyBzci0C70wRfDT63ziVLqsuztc7uKUHDPl9fuuCXM3F7wJawrZQ9E2aWxQJ8fcx0EsfxqciA6kszkLrrjVBB8bPF0D_VkdR_dHLkgiwdoUsMKA6wwxy2s8EWFLaywgRXuwgo7WGEHK2xghQFWGD4fotO3_cnrge8O3_BFokNipOb1Ki8SlWYip4rSRImYJ7IAGV_xUvKcl5RIoWCLiBORqzJKRUh4EUlOeRTvo71qXslHCIu4TEFw5VRyRQlRuQpLmXEpQk5USmYeCuq3yISrTK8PSPnGjIaaEhYSNjj7yOKIUQav3UMvmgELW5Tl910Pt8jS9HcQ8NBBTSbmVvaSRWECUhtIsx561vwLbFf70ngl5-slS4si04nbHtq3tG0m1gpVnMHE_hatmX35zCjlUZrrCK_cONd0YQeSP_7Dgx6gW-16e4L2VpdreQjy8Kp8atD7C4kwr4I |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+for+a+difference+in+nitric+oxide+biosynthesis+between+healthy+women+and+men&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=FORTE%2C+P&rft.au=KNEALE%2C+B.+J&rft.au=MILNE%2C+E&rft.au=CHOWIENCZYK%2C+P.+J&rft.date=1998-10-01&rft.pub=Lippincott&rft.issn=0194-911X&rft.volume=32&rft.issue=4&rft.spage=730&rft.epage=734&rft_id=info:doi/10.1161%2F01.hyp.32.4.730&rft.externalDBID=n%2Fa&rft.externalDocID=2421241 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |